Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Aerobiology and pollution (1)
  • Allergen immunotherapy (9)
  • Allergy diagnosis (15)
  • Allied health and primary care (1)
  • Anaphylaxis (14)
  • Artificial Intelligence (1)
  • Asthma (2)
  • Basic immunology (1)
  • Biomarkers (1)
  • Drug allergy (3)
  • ENT (1)
  • Food allergy (8)
  • Immune deficiencies and autoimmunity (1)
  • x Insect venom hypersensitivities (3)
  • Mastocytosis and mast cells (1)
  • One Health (1)
  • Prevention (1)
Poster available until
Poster categories
  • Thematic Poster Session (3)
keywords
Session Reference
  • L-TPS09 (1)
  • L-TPS11 (2)
  • x L-TPS18 (3)
  • TPS32 (2)
  • TPS37 (1)
  • TPS72 (6)
3 results
Thumbnail

D3.195 - Reasons for declining venom immunotherapy and its burden on patients' daily lives

Thumbnail

D3.198 - Hymenoptera Venom Allergy: A Case Report on Safe Discontinuation After Five Years of Venom Immunotherapy

Thumbnail

D3.203 - Yeast surface display as platform for generation of nanobodies to single allergens and allergen extracts

Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM